Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Narrative review: aspirin resistance and its clinical implications.

Sanderson S, Emery J, Baglin T, Kinmonth AL.

Ann Intern Med. 2005 Mar 1;142(5):370-80. Review.

PMID:
15738456
2.

Aspirin resistance.

Ashwin KA, Bairy KL, Vidyasagar S, Verma M, Prashanth CK, Sachidananda A.

Indian J Physiol Pharmacol. 2007 Apr-Jun;51(2):109-17. Review.

PMID:
18175654
3.

The role of aspirin in cardiovascular prevention: implications of aspirin resistance.

Gasparyan AY, Watson T, Lip GY.

J Am Coll Cardiol. 2008 May 13;51(19):1829-43. doi: 10.1016/j.jacc.2007.11.080. Review.

4.

Clinical implications of aspirin resistance.

Patel D, Moonis M.

Expert Rev Cardiovasc Ther. 2007 Sep;5(5):969-75. Review.

PMID:
17867925
5.

Aspirin resistance: biological and clinical implications.

Tseeng S, Arora R.

J Cardiovasc Pharmacol Ther. 2008 Mar;13(1):5-12. doi: 10.1177/1074248407310869. Review.

PMID:
18287586
6.

Aspirin resistance: current concepts.

Mason PJ, Freedman JE, Jacobs AK.

Rev Cardiovasc Med. 2004 Summer;5(3):156-63. Review.

PMID:
15346099
7.

[Aspirin resistance].

Miyata S, Miyata T, Kada A, Nagatsuka K.

Brain Nerve. 2008 Nov;60(11):1357-64. Review. Japanese.

PMID:
19069170
8.

Aspirin resistance: is this term meaningful?

Violi F, Pignatelli P.

Curr Opin Hematol. 2006 Sep;13(5):331-6. Review.

PMID:
16888437
9.
10.

Association of laboratory-defined aspirin resistance with a higher risk of recurrent cardiovascular events: a systematic review and meta-analysis.

Snoep JD, Hovens MM, Eikenboom JC, van der Bom JG, Huisman MV.

Arch Intern Med. 2007 Aug 13-27;167(15):1593-9. Review.

PMID:
17698681
11.

Enhanced antiplatelet effect of clopidogrel in patients whose platelets are least inhibited by aspirin: a randomized crossover trial.

Eikelboom JW, Hankey GJ, Thom J, Claxton A, Yi Q, Gilmore G, Staton J, Barden A, Norman PE.

J Thromb Haemost. 2005 Dec;3(12):2649-55.

12.

Aspirin resistance in cardiovascular disease: pathogenesis, diagnosis and clinical impact.

Papathanasiou A, Goudevenos J, Tselepis AD.

Curr Pharm Des. 2009;15(10):1085-94. Review.

PMID:
19355950
13.

Aspirin resistance: fact or fiction?

Oliveira DC, Silva RF, Silva DJ, Lima VC.

Arq Bras Cardiol. 2010 Sep;95(3):e91-4. Review.

14.

Lack of aspirin effect: aspirin resistance or resistance to taking aspirin?

Cotter G, Shemesh E, Zehavi M, Dinur I, Rudnick A, Milo O, Vered Z, Krakover R, Kaluski E, Kornberg A.

Am Heart J. 2004 Feb;147(2):293-300.

PMID:
14760328
15.

[Aspirin resistance 2003: a review of the literature].

Christiaens L, Macchi L.

Arch Mal Coeur Vaiss. 2004 Apr;97(4):320-6. Review. French.

PMID:
15182075
16.

Antiplatelet drug response variability and the role of platelet function testing: a practical guide for interventional cardiologists.

Angiolillo DJ, Suryadevara S, Capranzano P, Zenni MZ, Guzman LA, Bass TA.

Catheter Cardiovasc Interv. 2009 Jan 1;73(1):1-14. doi: 10.1002/ccd.21782. Review.

PMID:
19089929
17.

Aspirin resistance.

Tran HA, Anand SS, Hankey GJ, Eikelboom JW.

Thromb Res. 2007;120(3):337-46. Epub 2007 Jan 22. Review.

PMID:
17241655
18.

Residual platelet reactivity on aspirin therapy and recurrent cardiovascular events--a meta-analysis.

Sofi F, Marcucci R, Gori AM, Abbate R, Gensini GF.

Int J Cardiol. 2008 Aug 18;128(2):166-71. doi: 10.1016/j.ijcard.2007.12.010. Epub 2008 Feb 1. Review.

PMID:
18242733
19.

Drug insight: aspirin resistance--fact or fashion?

Patrono C, Rocca B.

Nat Clin Pract Cardiovasc Med. 2007 Jan;4(1):42-50. Review.

PMID:
17180149
20.

[Frequency and characteristics of aspirin resistance in Chilean cardiovascular patients].

Dussaillant N G, Zapata M M, Fardella B P, Conte L G, Cuneo V M.

Rev Med Chil. 2005 Apr;133(4):409-17. Epub 2005 Jun 8. Spanish.

Supplemental Content

Support Center